Interferon alfa-2b in renal transplant recipients with viral chronic hepatitis: A pilot study

被引：0
|
作者：
Monteon, FJ
Contreras, AM
Espinoza, L
Vazquez, G
Aguilar, S
Cueva, L
机构：
[1] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT NEPHROL,GUADALAJARA,JALISCO,MEXICO
[2] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[3] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[4] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT PATHOL,GUADALAJARA,JALISCO,MEXICO
[5] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT MICROBIOL,GUADALAJARA,JALISCO,MEXICO
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3306 / 3308
页数：3
相关论文
共 50 条
  • [31] Treatment of acute hepatitis C with interferon alfa-2b
    Muir, AJ
    Rockey, DC
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (14): : 1091 - 1092
  • [32] Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B
    Kaymakoglu, Sabahattin
    Oguz, Dilek
    Gur, Gurden
    Gurel, Selim
    Tankurt, Ethem
    Ersoz, Galip
    Ozenirler, Seren
    Kalayci, Cem
    Poturoglu, Sule
    Cakaloglu, Yilmaz
    Okten, Atilla
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) : 3020 - 3022
  • [33] Treatment with Peg-interferon alfa-2b in patients affected by acute hepatitis C: A pilot study
    Scotto, G
    Palumbo, E
    Fazio, V
    Cibelli, DC
    Saracino, A
    Angarano, G
    HEPATOLOGY, 2004, 40 (04) : 331A - 331A
  • [34] Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, J
    Weaver, L
    Schafer, DF
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 3042 - 3044
  • [35] Treatment of acute hepatitis C with interferon alfa-2b
    Jaeckel, E
    Cornberg, M
    Wedemeyer, H
    Santantonio, T
    Mayer, J
    Zankel, M
    Pastore, G
    Dietrich, M
    Trautwein, C
    Manns, MP
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20): : 1452 - 1457
  • [36] Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
    Wong, JB
    Davis, GL
    Pauker, SG
    AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 366 - 373
  • [37] A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C
    Shakil, AO
    McGuire, B
    Crippin, J
    Teperman, L
    Demetris, AJ
    Conjeevaram, H
    Gish, R
    Kwo, P
    Balan, V
    Wright, TL
    Brass, C
    Rakela, J
    HEPATOLOGY, 2002, 36 (05) : 1253 - 1258
  • [38] Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
    Flanigan, RC
    Salmon, SE
    Blumenstein, BA
    Bearman, SI
    Roy, V
    McGrath, PC
    Caton, JR
    Munshi, N
    Crawford, ED
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23): : 1655 - 1659
  • [39] Interferon alfa in the treatment of chronic viral hepatitis B and C
    Woo, MH
    Burnakis, TG
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (03) : 330 - 337
  • [40] 10 mega units interferon alfa-2b thrice weekly is superior to 5 mega units interferon alfa-2b thrice weekly as therapy for chronic hepatitis B
    Leung, NW
    Tam, JS
    Liew, CT
    Tsang, SW
    Chan, HL
    HEPATOLOGY, 2002, 36 (04) : 634A - 634A
12345